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Cervical cancer, a potentially preventable disease, has its main aetiology in infection by high risk
human papillomavirus (HR-HPV). Approaches to improving cervical cancer screening and
diagnostic methodologies include molecular biological analysis, targeting of biomarker proteins,
but also exploration and implementation of new techniques such as vibrational spectroscopy. This
study correlates the biomarker protein p16INK4A expression levels dependent on HPV copy number
with the infrared absorption spectral signatures of the cervical cancer cell lines, HPV negative
C33A, HPV-16 positive SiHa and CaSki and HPV-18 positive HeLa. Confocal fluorescence
microscopy demonstrated that p16 INK4A is expressed in all investigated cell lines in both nuclear
and cytoplasmic regions, although predominantly in the cytoplasm. Flow cytometry was used to
quantify the p16 INK4A expression levels and demonstrated a correlation, albeit nonlinear, between
the reported number of integrated HPV copies and p16 INK4A expression levels. CaSki cells were
found to have the highest level of expression, HeLa intermediate levels, and SiHa and C33A the
lowest levels. FTIR spectra revealed differences in nucleic acid, lipid and protein signatures
between the cell lines with varying HPV copy number. Peak intensities exhibited increasing
tendency in nucleic acid levels and decreasing tendency in lipid levels with increasing HPV copy
number, and although they were found to be nonlinearly correlated with the HPV copy number,
their dependence on p16 INK4A levels was found to be close to linear. Principal Component Analysis
(PCA) of the Infrared absorption spectra revealed differences between nuclear and cytoplasmic
spectroscopic signatures for all cell lines, and furthermore clearly differentiated the groups of
spectra representing each cell line. Finally, Partial Least Squares (PLS) analysis was employed to
construct a model which can predict the p16 INK4A expression level based on a spectral fingerprint
of a cell line, demonstrating the diagnostic potential of spectroscopic techniques.
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Cervical cancer is a potentially preventable disease and it
remains the second most common malignancy in women
worldwide 1. The incidence rates range from less than 15 per
100,000 in Europe up to 33.5 per 100,000 in Latin America 2.
Many aetiological factors are associated with cervical cancer,
such as diet, cigarette smoking, multiple sexual partners,
multiple pregnancies, contraceptive pills, sexually transmitted
diseases (Chlamydia, HIV) or aging. However, the most
important factor identified is infection with high risk human
papillomavirus (HR-HPV) 3. There are 15 identified HR-HPV
types 4 and 70% of all cervical cancers are associated with
either HPV-16 or HPV-18.
Differentially expressed proteins in cancer have potential
utility as biomarkers. As the cell cycle is often disrupted in a
cancerous cell, proteins associated with it are often candidate
biomarkers. Putative biomarkers of cervical cancer that are
currently under study include proteins such as CDC 6 (DNA
licensing protein), minichromosome maintenance proteins
(MCM 2, MCM 5), p53 or p16INK4A 5. These biomarkers have
been used to detect the presence of abnormal cells, based upon
This journal is © The Royal Society of Chemistry [year]
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immunocytochemical methods.
p16INK4A regulates the levels of active cyclin D/CDK in the
cell, providing a feedback mechanism that regulates the levels
of MCM (minichromosome maintenance proteins), PCNA
(proliferating-cell nuclear antigen)
and
cyclin
E.
Overexpression of p16INK4A, which is considered a marker of
elevated E7 expression, can be detected in some CIN1
(Cervical Intraepithelial Neoplasia grade 1) lesions, as well as
in CIN2 and CIN3 lesions that show evidence of integration 67
. Integration of the HPV genome into the host cell
chromosome is a critical event in the development of most
cervical cancers 8. Overexpression of p16INK4A has been
demonstrated in cervical cancers as a result of functional
inactivation of pRb by the HPV E7 protein 9. This
overexpression highlights the potential of p16INK4A as a
marker for CIN and cervical cancer. HPV positivity and
p16INK4A positivity have shown a correlation, even though
p16INK4A expression was also seen in a limited number of
HPV negative biopsy samples 10. Also, a correlation between
p16INK4A expression and cervical lesion grade and HR-HPV
positivity has been documented 11. p16INK4A has been proven
to be the most reliable marker of cervical dysplasia and was
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found to mark all grades of squamous and glandular lesions of
the cervix. The use of p16INK4A immunocytochemical analysis
as a complement to conventional screening programmes could
potentially aid in the reduction of false positive and false
negative results 12.
In the first part of this study, expression of p16 INK4A was
analysed
in
cervical
cancer
cell
lines
using
immunocytochemical staining and both confocal fluorescence
microscopy and flow cytometry. Confocal fluorescence
microscopy is an optical imaging technique that allows for
high-resolution structural imaging at the cellular level at
varying depths in the sample while flow cytometry is a well
established
technique
for
examining
and
sorting
fluorochrome-labeled
cells,
simultaneously
providing
assessment of a multitude of characteristics of individual
cells.
Four cervical cell lines were used in this study: HPV negative
C33A, HPV-18 positive HeLa containing 20-50 integrated
HPV copies per cell, HPV-16 positive CaSki containing 60600 integrated HPV copies per cell and SiHa with 1-2
integrated HPV-16 copies per cell.
The second part of the study utilised Fourier Transformed
Infrared (FTIR) Spectroscopy to spectroscopically fingerprint
and differentiate the cervical cancer cell lines. FTIR, along
with Raman spectroscopy, is a vibrational spectroscopic
technique which provides unique information about the
chemical composition of a sample. A wide range of biological
applications, particularly cancer detection, has been reported
to date 13-19. The development of applications of vibrational
spectroscopy to medical diagnostics has recently been
reviewed by Diem et al. 20. Significant activity in the area of
the potential application of FTIR spectroscopy to cervical
cancer detection has been reported over the last decade 17, 2143
. Understanding and processing the biochemical information
delivered by vibrational spectroscopic techniques and its
correlation with the existing screening and diagnostic methods
is key to further development of realistic applications of
Raman and FTIR spectroscopy to cervical cancer detection.
It has recently been demonstrated that both Raman and FTIR
absorption spectroscopy can effectively discriminate between
cell lines with varying HPV infection levels 44. The current
study explores the potential correlation of spectroscopic
features with HPV infection levels characteristic of each cell
line as well as the resultant expression levels of p 16INK4
biomarker.
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Confocal microscopy
For confocal microscopy, cells were grown on glass
coverslips in 6 well plates and stained as described above.
Each coverslip with the stained cells was removed from the
multi well plate and mounted upside down on a pre-labelled
glass slide using Sigma diagnostic mounting medium (SigmaAldrich, Ireland). Samples were left to dry in a dark room and
thereafter stored at 4°C until they were examined under the
confocal microscope.
Flow cytometry
Flow cytometry samples were stained as a pellet in Eppendorf
tubes according to the staining protocol described above.
Pellets were examined directly after the staining procedure.
FTIR spectroscopy
Cervical cell lines for FTIR study were grown for 24 hours on
CaF 2 windows. Cells prepared for FTIR study were not fixed
to avoid contibution of the fixative agent to the cellular
spectra 45. Before FTIR measurements, cells were washed
twice in PBS and dried to minimise contributions from water.
Measurements and data handling

Materials and Methods
Cell lines were obtained from the ATCC cell culture
collection. All cell lines were grown in RPMI 1640 medium
(Sigma-Aldrich, Ireland) supplemented with 10% Foetal
Bovine Serum (FBS, BioWhittaker®, Lonza, Ireland), 1%
Penicillin-Streptomycin (BioWhittaker®, Lonza, Ireland), 1%
L-glutamine
(Sigma-Aldrich,
Ireland),
and
0.2%
Hydrocortisone (Sigma-Aldrich, Ireland). Cells were
incubated at 37°C in 5% CO2 and maintained up to 70-80%
confluency.

Immunocytochemical staining for p16INK4A was performed on
each of the cell lines and appropriate negative controls. Cells
were fixed using 4% paraformaldehyde for 30mins, washed 3
times with phosphate buffered saline (PBS) and permeabilised
with cold methanol for 10mins. Cells were blocked by
incubating with blocking buffer (1% bovine serum albumin
(BSA) in PBS) for 30mins at room temperature with agitation.
After decanting the serum, cells were incubated for one hour
at 37°C with the primary antibody, purified mouse anti-human
p16INK4A (BD Pharmingen™, Ireland) in dilution buffer (1%
BSA in PBS). Following incubation, cells were washed 5
times with PBS and were incubated with the secondary
antibody, goat polyclonal to mouse Immunoglobulin G (IgG)
(Abcam, Ireland) labeled with fluorescein isothyocyanate
(FITC) in dilution buffer. This was carried out in darkness for
45mins at 37°C. The cells were additionally incubated with
propidium iodide (PI) staining solution (dilution 1:250) (BD
Pharmingen™, Ireland) for 15mins and washed 3 times with
PBS. A negative control was also prepared for each cultured
cell line according the same protocol but with no primary
antibody (NC1) and no primary or secondary antibody (NC2).
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Confocal fluorescence microscopy
An inverted confocal laser scanning fluorescence microscope
(LSM 510 META, Carl Zeiss) was used to record fluorescence
images of the cells. The argon ion laser was chosen to excite
the FITC fluorochromes at 488nm and the HeNe laser was
used to excite the PI fluorochromes at 543nm. A 63× oil
immersion objective lens was used for recording. Five to six
images were collected for each sample from different regions
of the slides.
Flow cytometry
A CyFlow® Space Flow cytometer System (Partec) was used
for the cervical cell analysis. Measurements were performed
for each cell line, represented by 2-4 samples, prepared as
stained cellular pellets. Fluorescence intensity of the staining
was calculated based on analysis of approx 2×104 cells for

This journal is © The Royal Society of Chemistry [year]

Fig. 1 Confocal microscopy images of cervical cell lines: A-B C33A cells, C-D SiHa cells, E-F HeLa cells, G-H CaSki cells. Images A,C, E and G show
FITC fluorescence staining (related to p16INK4A expression), while images B, D, F and H present FITC and PI staining.
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each sample. Analysis of the data set was performed using
FloMax 3.0 software. Gating R1 selected a well defined
population of cells excluding any possible debris present in
the samples. Gating R2 was performed to exclude doublets
and triplets of cells analysed by the instrument. The
subsequent step included applying gating G1 (logical gate of
R1 and R2) to the investigated fluorescence signal and
choosing the range of interest within which fluorescence
intensity calculations were performed.
Infrared spectroscopy
Fourier Transformed
Infrared (FTIR) spectroscopic
measurements were performed using a Perkin Elmer Spotlight
400 microscope system in transmission mode. The time frame
between washing the FTIR samples with PBS and start of
acquiring spectra was 30-40minutes. Spectra were collected as
an average of 64 scans with a resolution of 2cm-1 using Image
Mode. FTIR signals were accumulated over a spectral range
of 750 to 4000cm-1. Signals were accumulated with the
maximal imaging resolution of the system of 6.25µm per
pixel. The sampling included investigation of two cell culture
passages prepared on separate slides. Four to five cells per
slide were analysed.
Spectroscopic data analysis was carried out in Matlab, version
R2006 (Mathworks, CA, USA) according to protocols
developed and routinely used in DIT. Processing of the FTIR
spectra included an EMSC resonant Mie scattering correction
according to the algorithm developed by Bassan et al. 46 with
the Matrigel spectrum supplied with the algorithm used as
reference. In the original work, it was demonstrated using
simulated spectra that the algorithm, which iteratively evolves
the reference spectrum to fit and correct for both the resonant
and nonresonant scattering contributions, reproduces the ideal
spectra even using a “non-ideal” reference and that for
example the true position of the biologically significant
Amide I band can be obtained with the RMieS-EMSC
algorithm 46. After pre-processing the spectra, Principal
Component Analysis (PCA) and Partial Least Squares (PLS)

This journal is © The Royal Society of Chemistry [year]
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analysis were performed on the data set. It should be noted
that, although the spectra were recorded over the range 7504000cm-1, the Mie scattering correction was only executable
over the maximum range of the reference spectrum provided
with the algorithm, namely 1000-4000cm-1, and thus only this
region is described.

Results and Discussion
Confocal microscopy
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Fluorescence images of cells were collected using the
confocal fluorescence microscopy system. Representative
images of cells are presented in figure 1, where A, C, E and G
show only green fluorescence staining (FITC), while B, D, F
and H show the overlay of green (FITC) and red (PI)
fluorescence signals. The FITC fluorescence intensity is
associated with the p16 INK4A expression level, while the PI
dye was used to visualise the position of nuclei within the
cells. The fluorescence intensities for the defined FITC
fluorescence emission wavelengths for the samples stained
with primary and secondary antibody (p16INK4A staining) and
NC1 and NC2 samples were compared. The results revealed a
strong emission peak for samples stained with primary and
secondary antibody and negligible emission for the negative
control samples (NC1 and NC2) (data not shown). Based on
these observations, immunostaining was found to be specific
to p16INK4A . Figure 1 shows that purified mouse monoclonal
anti-human p16 INK4A stains both cytoplasmic and nuclear
regions of the cells, although staining is predominantly in the
cytoplasm. The presence of p16INK4A in the cytoplasmic
region may be a result of post transcriptional modification or
overexpression of the protein, which forces its transfer into
the cytoplasm 12. These findings support previous studies
confirming the theory that p16 INK4A is overexpressed in
dysplastic cells of the cervix 47. The observations are in very
good agreement with the work of Klaes et al., who
demonstrated that the p16INK4A specific immunohistochemical

Journal Name, [year], [vol], 00–00 | 3

Table 1 Quantitative analysis of fluorescence intensity related to p16INK4A expression level and negative control samples with no secondary antibody for
cervical cancer cell lines obtained from flow cytometry studies.
p16INK4A expression

Cell line

Negative controls (NC1)

Reported number
of HPV copies
per cell

Fluorescence
intensity

Standard deviation
for fluorescence intensity

Fluorescence
intensity

Standard deviation
for fluorescence intensity

(a.u.)

(a.u.)

(a.u.)

(a.u.)

0
1-2
20-50
60-600

61.92
68.14
80.10
94.31

1.42
1.23
1.92
1.77

1.32
1.18
1.17
1.41

0.06
0.08
0.01
0.11

C33A
SiHa
HeLa
CaSki
a
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staining allows for sensitive and specific identification of
dysplastic cervical cells in cervical cancer tissue sections and
cervical cancer cell lines 48. The results also support the
findings of Murphy et al., that p16INK4A marks dysplastic
squamous and glandular cells of the cervix with a sensitivity
of 99.9% and specificity of 100% 49. The negative HPV cell
line C33A was p16 INK4A positive (figure 1A-B), but exhibited
the lowest staining intensity of the investigated cell lines. This
finding confirms the previous study of Milde-Langosch et al.
in which p16INK4A overexpression was reported in 41% of
HPV negative adenocarcinomas and it was suggested that a
non-HPV E7 mediated mechanism of p16 INK4A up regulation
may also exist 50.
Quantitative analysis of the fluorescence intensity of FITC
visible in the confocal images, albeit on a limited number of
individual cells, indicated that there is a correlation between
the number of integrated HPV copies per cell and p16INK4A
expression characteristic to each cell line. CaSki cells were
found to have the highest intensity of staining, with
decreasing tendency for HeLa and SiHa and C33A expressing
the lowest intensity (data not shown).

50

55

Flow cytometry
To more precisely quantify expression of p16 INK4A protein in
cervical cancer cell lines, flow cytometry measurements were
performed to enable a larger statistical basis. For all the
investigated cell lines, the populations were well defined,
allowing for a precise investigation of the cells of interest.
Mean fluorescence intensity levels related to p16 INK4A
expression are presented in table 1 together with their
standard deviations. Values of fluorescence intensity for
negative control (NC1) samples prepared for the investigated
cell lines according to the immunostaining protocol but with
no primary antibody are also presented in table 1. Values of
fluorescence intensities for NC1 were lower than the standard
deviations for fluorescence intensities related to p16 INK4A
expression, confirming that the flow cytometry analysis was
specific to p16INK4A. A degree of correlation between the
number of HPV copies per cell line and the fluorescence
intensity related to p16INK4A expression was observed for the
flow cytometry data (figure 2). The highest level of p16INK4A
expression (intensity of staining) was observed for CaSki
cells, followed by HeLa, SiHa and the lowest for C33A. The
relationship between p16INK4A expression and HPV copy
number illustrated by figure 2 is supported by a study
4 | Journal Name, [year], [vol], 00–00
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Fig. 2 Fluorescence intensity related to the p16INK4A expression level in
cervical cancer cell lines plotted against the average HPV copy number
present in a cell with the fitted function. The dotted line is a fit of the data
with the equation y=a+b√x +cx, where a=62.4, b=3.5 and c=-0.1.

conducted by Klaes et al., wherein a correlation between
increasing grade of cervical lesion and staining intensity of
p16INK4A was observed 48. Similarly, Agoff et al. showed that
p16INK4A expression correlates with an increasing severity of
cervical disease 51. Murphy et al. showed a strong correlation
between HR-HPV positivity and p16INK4A staining pattern 12,
52-53
. In the study conducted by Wang et al. a correlation
between p16INK4A immunostaining and cervical disease
severity stratified by HPV status was observed 54. The results
in the present study demonstrate a correlation between

Fig. 3Visual images (A-D) and average absorbance FTIR maps (E-H)
representing cells present in the investigated samples. A and E – C33A
cell, B and F – SiHa cells, C and G – HeLa cells, D and H – CaSki cells.
Red colour represents region of a nucleus, green and light blue – region of
a cytoplasm, violet – background.

This journal is © The Royal Society of Chemistry [year]

Table 2. Assignments 55 of FTIR bands of cellular spectra recorded from cervical cancer cells. Wavenumbers in brackets are attributed to peaks
characteristic of cytoplasmic spectra that were noticed to be shifted with respect to peaks corresponding to nuclear constituents.
Wavenumber
Peak no.

(cm-1)

Assignment

Proteins

+

I

1036

C-C skeletal stretching

II

1070 (1082)

symmetric PO2 str. mode

III

1120

C-O stretching

IV

1170

CO-OC asymmetric stretching

+
+

Lipids

Nucleic acids

DNA, RNA
RNA

V

1240

Amide III , asymmetric PO2 str. mode

VI

1310 (1316)

CH2 stretching

DNA, RNA
+

VII

1400

CH3 symmetric deformations

+

VIII

1450

CH3 asymmetric deformations

+

IX

1550

C-N stretching and CHN bending -Amide II

+
+

+

X

1650

C=O stretching - Amide I

XI

2854

CH2 symmetric stretching

XII

2875

CH3 symmetric stretching

+

XIII

2926

CH2 asymmetric stretching

+

XIV

2962

CH3 asymmetric stretching

XV

3292 (3300)

N-H stretching (Amide A)

+

+
+

DNA, RNA

a
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p16INK4A immunostaining and the presence of HR-HPV in
cervical cancer cell lines supporting the previous studies and
implies that p16INK4A is a highly sensitive marker of HR-HPV in
cervical cancer cell lines. The hyperbolic-like relationship
between the levels of p16INK4A and HPV copy number is typical
of the response of a cell to the action of an agonist 56 and in figure
2, is approximated by a fit with the following function y=a+b√x
+cx, where a=62.4, b=3.5 and c=-0.1. It should be noted that, in
figure 2, the HPV copy number is represented by the average of
the range quoted in literature 57-58 and so error margins in the
horizontal axis are potentially very large. However, the sublinear
nature of the plot indicates that p16INK4A expression levels are
particularly sensitive for low HPV copy number.
FTIR spectroscopy
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FTIR maps were recorded for C33A, SiHa, HeLa and CaSki
cells (2-4 maps for each cell line) using the Perkin Elmer
Spotlight 400 system. Representative images are presented in
figure 3 (A-D). Representative unprocessed FTIR maps,
generated by the Spectrum Image software, showing
spectrally averaged absorbances, recorded from the regions of
interest within the investigated samples are shown in figure 3,
E, F, G and H, for C33A, SiHa, HeLa and CaSki, respectively.
Nuclear and cytoplasmic regions are well defined, due to their
varying density and thickness, in the FTIR maps. Spectra
representing nuclear and cytoplasmic regions of the cells were
extracted from the FTIR maps using the Perkin Elmer
Spectrum IMAGE software and delivered mean spectra of
cellular structures characteristic of the cell lines (figure 4).
Spectra extracted from the maps were chosen from the middle
of the nucleus or cytoplasm. As a result, from 60-80 spectra
recorded for one cell, only a few of them were used in the
analysis. This procedure ensured that only nuclear or
cytoplasmic signals were compared rather than a mix of the
cellular signatures. Each spectrum from figure 4 was
This journal is © The Royal Society of Chemistry [year]
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Fig. 4 Mean FTIR spectra of cervical cancer cell lines representing
regions of cells (nucleus and cytoplasm).

calculated as an average of 30-40 signals extracted from the
FTIR maps characteristic of the defined cellular structure and
was subjected to pre-processing using the RMieS-EMSC
algorithm. Assignments of the main FTIR bands (numbered in
figure 4) are presented in table 2. Three main biochemical
cellular components feature strongly: proteins, lipids and
nucleic acids. For all cell lines, the nuclear and cytoplasmic
regions exhibited similar FTIR bands related to the vibrations
of these constituent components. There were, however,
differences in the band intensities. A distinctive reduction of
lipids was noticed in the IR signal of the cytoplasm compared
to the signal of the nucleus, manifest in the CH2 and CH3
groups stretching bands in the range of 2850cm-1 – 2970cm-1,
due to the double lipid bilayer nuclear envelope, compared to
the phospholipid bilayer membrane of the cytoplasm.
Furthermore, the peak at 1120cm-1 is present only in the
cytoplasm. This feature is related to vibrations of RNA
components, which are mainly present in the cytoplasmic
organelles. Three peaks related to cytoplasmic constituent
Journal Name, [year], [vol], 00–00 | 5

Fig. 5 Peak intensity analysis for FTIR spectra of nuclear and cytoplasmic regions of cervical cancer cells. Dependence of peak intensities vs. HPV copy
number was fit with y=a+b√x +cx function, while peak intensities vs. fluorescence intensities (p16INK4A expression level) was fit with a linear function,
y=a+bx.
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vibrations were also noticed to be shifted to higher
wavenumbers (1082cm-1, 1316cm-1, 3300cm-1) compared to
nuclear bands related to the same types of vibration (1070cm1
, 1310cm-1, 3292cm-1). A detailed examination of the relative
intensities of peaks related to vibrations of the cellular
components (nucleus and cytoplasm) of the C33A, SiHa,
HeLa and CaSki infrared spectra revealed the following
tendencies:
•
Increase in nucleic acid levels with increasing
number of HR-HPV copies in the cell or increasing
p16INK4A expression (figure 5A, 5D),
•
Decrease in lipid levels with increasing number of
HR-HPV copies in the cell or increasing p16INK4A
expression (figure 5B, 5E),
6 | Journal Name, [year], [vol], 00–00

No tendency for changes in protein levels related to
HR-HPV copy number or increasing p16INK4A
expression (figure 5C, 5F).
As the RMieS-EMSC correction uses the protein based
Matrigel as a reference and effectively normalises the protein
levels, the third observation is not surprising, and variations in
nucleic acids and lipid related features should be considered
relative to the protein levels.
The observed increase in nucleic acid levels may be related to
an increased number of chromosomes present in HPV infected
nuclei. It was reported by Mehés et al. that HPV presence
facilitates polyploidisation (increase in chromosome number
in a cell nucleus) in cervical squamous cells 59. Additionally,
it is known that binding of HPV DNA to host DNA disrupts
•
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Fig. 6 Principal component analysis results. A – scatterplots presented in
three and two dimensional form, B – principal component loadings with
marked regions of the main biocomponent contribution.
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the normal function of the cellular proteins and as a
consequence, the host cell accumulates more and more
damaged DNA that cannot be repaired 60.
CaSki cells are known to be the most malignant and in the
spectra of the cytoplasm and nucleus representing this cell
line the highest level of nucleic acids was observed. A similar
increase of the nucleic acid related peaks in cancerous
cervical cells was noticed in previous studies 33, 42 and is
confirmed by these observations. Changes in lipid levels are
possibly associated with the disruption of the membrane
functionality caused by the virus which influences lipid rafts
61
. A similar behaviour was noted and reported in our previous
study on cervical cancer cell lines, wherein both Raman and
FTIR (point mode) techniques were utilised 62. Moreover, it
was reported previously by Wong et al. that the degree of
disorder of methylene chains in membrane lipids increases in
cervical neoplastic cells 63. The absence of any clear
relationship between protein levels and HPV copy number is
expected, as the presence of HR-HPV in the cell results in
functional over- and under- expression of only select
biomarker proteins 5, while the level of the other proteins
would not be affected. The variation of the spectroscopic
features associated with the nuclear lipids, proteins and
nucleic acids as a function of the HPV copy number was
found to be sublinear and to be well fitted with a similar
function to that employed to describe the variation of the
p16INK4A levels with HPV copy number in figure 2. Notably,
the dependences of the cytoplasmic lipids, proteins and
nucleic acids on the p16INK4A levels, as identified by
fluorescence were found to be linear.
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Figure 6 shows the results of Principal Component Analysis
This journal is © The Royal Society of Chemistry [year]

(PCA) of the spectral data for the four cell lines. The analysis
clearly differentiates between nuclear and cytoplasmic FTIR
signals for each cell line. The percentage variance explained
by the first three principal components was 88.34%, 4.44%
and 2.23% for PC1, PC2 and PC3, respectively. The PCA
scatterplot (figure 6A) reveals that the cytoplasm spectra of
C33A and SiHa are close to each other, suggesting similarities
in cytoplasmic composition of these cell lines. However, in
terms of the nuclear data, the cell lines are very well
separated. C33A are HPV negative, while SiHa contain a very
low number of integrated HPV copies per cell (1-2). HPV
DNA and host cell DNA integration occurs within the nucleus
of a cell. Thus, the differences between C33A (HPV negative
- no integration) and SiHa (HPV positive - integration) at the
nuclear level are understandable. It is possible, that in the
cytoplasm, biochemical changes in the cell affected by a very
low number of HPV copies are not as prominent as in the
nucleus. In the case of cells infected by 20-50 HPV copies
(HeLa) and 60-600 copies (CaSki), biochemical changes
within the cytoplasm become more prominent resulting in, for
example, a stronger under- and overexpression of cytoplasmic
proteins. Thus the cytoplasmic signals of C33A and SiHa are
distributed close to each other, while HeLa and CaSki are very
well separated. In general, the clusters representing the
spectra of cytoplasm are more dispersed than those
corresponding to cell nuclei. This could be explained by the
fact that the cytoplasm is much more variable in its
composition compared to the nucleus, therefore exhibiting
more variation in the FTIR signals. Although, the Resonant
Mie scattering correction algorithm cannot be considered
perfect as evidenced by the incomplete baseline correction in
the loadings plots of the PCs, (figure 6B), it is considered the
most effective method currently available allowing for
removing the Mie scattering influence from the FTIR signals.
The separation between the nuclear and the cytoplasmic
clusters is clearly due to the first principal component (PC1).
Based on the PC1 loading (figure 6B), it can be concluded
that the biochemical variability between these two cellular
components primarily arises from the lipid levels (region of
2800-3000cm-1). In PC1, protein contributions are also
notable (1400-1700cm-1, 3000-3500cm-1). PC1 also shows
nucleic acid variations (1050-1200cm-1), the symmetric
phosphodiester group stretching band in RNA (peak at
1120cm-1) being strongly accented in cytoplasm spectra. This
observation is consistent with the mean spectra analysis,
whereby the peak at 1120cm-1 was seen to be prominent in the
spectra of the cytoplasm of all cell lines and absent in the
signals from nuclei (figure 4 – peak III in enlarged nucleic
acid region). PC2 indicates a high variability of the proteins
(Amide I, Amide II, Amide III, Amide A). This separation of
the cell lines confirms the study of Kelly et al., where amide
bands were also determined to be a source of differentiation of
the cervical cancer cells 27. In PC2 there is also a lipid
contribution present originating from symmetric and
asymmetric vibrations of the CH2 and CH3 groups. A two
dimensional representation of the scatterplot PC1 vs. PC2
(figure 6A) shows that the internal variability of the
cytoplasm signals is extended along PC2. Therefore, it can be
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loadings and the PLS loading, is the lipid contribution. Again,
the presence of HR-HPV is seen to significantly influence the
lipid balance within the cell 61, and thus it can be expected
that the vibrations of lipid component groups differentiate
cells with various HPV copy number. This differentiation was
distinctly manifest in the mean spectra of the cytoplasm and
nucleus (figure 4 – enlarged lipid region of 2800-3050cm-1).
Furthermore, the DNA and RNA related peaks are exhibited
in the range of 1050-1250cm-1,(sym. and asym. PO2 str. CO
str.) and 3200-3400cm-1. Such activity in the region of the
nucleic acid features is consistent with the profile of PC1 and
PC3 (figure 6B), which differentiates the cell line signals, and
as a consequence distinguishes cells as a function of HPV
copy number.

Conclusions

55

Fig. 7 Partial Least Squares analysis results targeting the p16INK4A
expression level prediction based on the FTIR spectral features.
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10

concluded that it originates mainly from variations in the
protein levels within the cell. Groups of points in the PCA
scatterplot representing the spectroscopic signatures of C33A,
SiHa, HeLa and CaSki cell lines recorded from nuclei are
separated along the third principal component. In PC3
contributions of all components are present; nucleic acids,
lipids and proteins. This illustrates that the HR-HPV infection
influences the entire biochemistry of the cell through a chain
of reactions 64.
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In order to further elucidate the multivariate spectral
signatures which are specifically related to HPV infection,
Partial Least Squares (PLS) analysis was performed. Figure 5
demonstrates that p16INK4A levels as measured by fluorescence
intensity are approximately linearly correlated with the
univariate spectral features and thus, as PLS is a linear model,
these values are employed as targets for the PLS analysis. The
model can therefore be applied to the FTIR data to elucidate
multivariate signatures which are correlated to p16 INK4A
expression level, and therefore, in accordance with figure 2, to
HPV infection levels. Once established, these variation
patterns can then be applied to unknown samples to screen for
the biomarker levels. As p16INK4A was found to be
predominantly expressed in cytoplasmic regions of the cells,
signals recorded from the cytoplasm were utilised in the
analysis. Calibration (based on 40% of the data) and test set
performance (based on 60% of the data) are presented in
figure 7A and demonstrate a very good fit to the model. As
shown in figure 7B, the PLS loading exhibits variations
originating from proteins, primarily as sub-bands of Amide A
(3000-3700cm-1) and Amide III (1230-1250cm-1), and are
associated with the chain of biochemical disruption in protein
regulation caused by HPV presence 64Another prominent
spectral feature differentiating the cell lines, and present in PC
8 | Journal Name, [year], [vol], 00–00
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Confocal fluorescence microscopy and flow cytometry
revealed that p16INK4A expression levels were correlated with
HPV infection levels in cervical cancer cell lines. This
confirms p16INK4A as a potential diagnostic marker of cervical
cancer, supporting the results of many other studies 47-48, 65.
Integration of HR-HPV sequences into the cell genome is
considered to be an important event in the progression of
cervical neoplasia. In this study, a correlation between the
integrated HPV copy number and intensity of p16INK4A was
observed. FTIR imaging allowed for identification of the
specific spectral features of nuclear and cytoplasmic regions
of the cervical cancer cells, indicating the differences between
the two, in terms of lipid and RNA levels. PCA analysis
revealed that the spectral analysis clearly separates the nuclear
and cytoplasmic characteristic signals, and additionally
distinguishes the cell lines. At low copy number, HPV
predominantly influences the nucleus of the cell, whereas
increased copy number impacts on the cytoplasmic signatures.
A model of p16INK4A expression level prediction based on
FTIR spectroscopy was constructed utilising PLS analysis.
Modelling was predominantly based on spectral features
arising from nucleic acid, lipid and protein contributing
features, which are influenced by the HPV interaction with the
host cell. Notably, this work proves that the wavenumbers
above 2700cm-1 may exhibit crucial information. This region
of the FTIR spectrum has been neglected in many studies
conducted on biological samples.
A potential application of vibrational spectroscopy to cervical
cancer screening and diagnosis requires a full understanding
of the spectral information and its correlation with existing
screening and diagnostic methods such as Pap testing or
colposcopy. However, the field of the cervical cancer
recognition and detection is still developing with new
biomarkers 5 being identified that may be considered as
adjuncts to existing cervical cytology and pathology
methods. Biomarkers such as p16 INK4A have been found to be
useful for low-grade lesions 66-69 making them particularly
attractive. Thus, a correlation and explanation of the spectral
information with these new biomarkers is a new challenge for
biospectroscopists working on future cancer diagnostic
systems.

This journal is © The Royal Society of Chemistry [year]

Acknowledgement

5

This work was funded by the Department of Education and
Science Technological Sector Research Strand III programme
and enabled through the National Biophotonics and Imaging
Platform, Ireland, and the Integrated NanoScience Platform
for Ireland, both funded by the Irish Government's Programme
for Research in Third Level Institutions, Cycle 4, National
Development Plan 2007-2013.

17.

60

19.
20.
65

21.

Notes and references
10

15

a

RESC, Focas Research Institute, Dublin Institute of Technology, Kevin
Street, Dublin 8, Ireland. E-mail: kamila.m.ostrowska@gmail.com.
b
School of Biological Sciences, Dublin Institute of Technology, Kevin
Street, Dublin 8, Ireland.
c
Department of Pathology, Coombe Women & Infants University
Hospital, Dolphin’s Barn Street, Dublin 8, Ireland.
d
Focas Research Institute, Dublin Institute of Technology, Kevin Street,
Dublin 8, Ireland.

18.

22.
70

23.
24.
25.

75

20

1.
2.
3.

25

4.

5.
30

6.
7.
35

8.
9.

40

10.

11.
45

12.

13.
50

14.
15.
55

16.

D. Parkin, F. Bray, J. Ferlay and P. Pisani, CA Cancer J Clin,
2002, 55, 74-108.
D. Parkin and F. Bray, Vaccine, 2006, 24 Suppl 3, S3/11-25.
J. Walboomers, M. Jacobs, M. Manos, F. Bosch, J. Kummer, K.
Shah, P. Snijders, J. Peto, C. Meijer and N. Muñoz, J Pathol, 1999,
189, 12-19.
N. Munoz, F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague,
K. V. Shah, P. J. Snijders and C. J. Meijer, N Engl J Med, 2003,
348, 518-527.
C. M. Martin, L. Kehoe, C. O. Spillane and J. J. O'Leary, Mol
Diagn Ther, 2007, 11, 277-290.
A. Kalof, M. Evans, L. Simmons-Arnold, B. Beatty and K. Cooper,
Am J Surg Pathol, 2005, 29, 674-679.
M. Dray, P. Russell, C. Dalrymple, N. Wallman, G. Angus, A.
Leong, J. Carter and B. Cheerala, Pathology, 2005, 37, 112-124.
T. Yu, M. J. Ferber, T. H. Cheung, T. K. Chung, Y. F. Wong and
D. I. Smith, Cancer Genet Cytogenet, 2005, 158, 27-34.
N. Ozgul, A. Cil, G. Bozdayi, A. Usubutun, D. Bulbul, S. Rota, M.
Kose, A. Biri and A. Haberal, J Obstet Gynaecol Res, 2008, 34,
865-871.
N. Murphy, M. Ring, C. Heffron, B. King, A. Killalea, C. Hughes,
C. Martin, E. McGuinness, O. Sheils and J. O'Leary, J Clin Pathol,
2005, 58, 525-534.
N. Missaoui, S. Hmissa, L. Frappart, A. Trabelsi, A. Ben
Abdelkader, C. Traore, M. Mokni, M. T. Yaacoubi and S. Korbi,
Virchows Arch, 2006, 448, 597-603.
N. Murphy, M. Ring, A. G. Killalea, V. Uhlmann, M. O'Donovan,
F. Mulcahy, M. Turner, E. McGuinness, M. Griffin, C. Martin, O.
Sheils and J. J. O'Leary, J Clin Pathol, 2003, 56, 56-63.
S. Candefjord, K. Ramser and O. A. Lindahl, J Med Eng Technol,
2009, 33, 585-603.
C. Kendall, M. Isabelle, F. Bazant-Hegemark, J. Hutchings, L. Orr,
J. Babrah, R. Baker and N. Stone, Analyst, 2009, 134, 1029-1045.
C. Krafft, G. Steiner, C. Beleites and R. Salzer, J Biophotonics,
2009, 2, 13-28.
F. Bazant-Hegemark, K. Edey, G. R. Swingler, M. D. Read and N.
Stone, Technol Cancer Res Treat, 2008, 7, 483-496.

This journal is © The Royal Society of Chemistry [year]

26.
27.
80

28.

85

29.
30.

31.
90

32.

95

33.
34.
35.

100

36.
37.
105

38.
39.
110

40.

M. J. Walsh, M. J. German, M. Singh, H. M. Pollock, A.
Hammiche, M. Kyrgiou, H. F. Stringfellow, E. Paraskevaidis, P. L.
Martin-Hirsch and F. L. Martin, Cancer Lett, 2007, 246, 1-11.
N. S. Eikje, K. Aizawa and Y. Ozaki, Biotechnol Annu Rev, 2005,
11, 191-225.
R. J. Meier, Chem Soc Rev, 2005, 34, 743-752.
M. Diem, J. M. Chalmers and P. R. Griffiths, Vibrational
spectroscopy for medical diagnosis, John Wiley & Sons,
Chichester, England ; Hoboken, NJ, 2008.
J. I. Chang, Y. B. Huang, P. C. Wu, C. C. Chen, S. C. Huang and
Y. H. Tsai, Gynecol Oncol, 2003, 91, 577-583.
L. Chiriboga, P. Xie, H. Yee, D. Zarou, D. Zakim and M. Diem,
Cell Mol Biol (Noisy-le-grand), 1998, 44, 219-229.
L. Chiriboga, H. Yee, M. Diem and B. Wood, Gynecol Oncol,
2003, 91, 275-276; author reply 276-277.
M. A. Cohenford, T. A. Godwin, F. Cahn, P. Bhandare, T. A.
Caputo and B. Rigas, Gynecol Oncol, 1997, 66, 59-65.
S. G. El-Tawil, R. Adnan, Z. N. Muhamed and N. H. Othman,
Pathology, 2008, 40, 600-603.
M. Fung Kee Fung, M. Senterman, P. Eid, W. Faught, N. Z.
Mikhael and P. T. Wong, Gynecol Oncol, 1997, 66, 10-15.
J. G. Kelly, K. T. Cheung, C. Martin, J. J. O'Leary, W. Prendiville,
P. L. Martin-Hirsch and F. L. Martin, Clin Chim Acta, 2010, 411,
1027-1033.
C. M. Krishna, G. D. Sockalingum, B. M. Vadhiraja, K.
Maheedhar, A. C. Rao, L. Rao, L. Venteo, M. Pluot, D. J.
Fernandes, M. S. Vidyasagar, V. B. Kartha and M. Manfait,
Biopolymers, 2007, 85, 214-221.
S. R. Lowry, Cell Mol Biol (Noisy-le-grand), 1998, 44, 169-177.
S. Mark, R. K. Sahu, K. Kantarovich, A. Podshyvalov, H.
Guterman, J. Goldstein, R. Jagannathan, S. Argov and S.
Mordechai, J Biomed Opt, 2004, 9, 558-567.
S. Mordechai, R. K. Sahu, Z. Hammody, S. Mark, K. Kantarovich,
H. Guterman, A. Podshyvalov, J. Goldstein and S. Argov, J
Microsc, 2004, 215, 86-91.
B. J. Morris, C. Lee, B. N. Nightingale, E. Molodysky, L. J.
Morris, R. Appio, S. Sternhell, M. Cardona, D. Mackerras and L.
M. Irwig, Gynecol Oncol, 1995, 56, 245-249.
S. Neviliappan, L. Fang Kan, T. Tiang Lee Walter, S. Arulkumaran
and P. T. Wong, Gynecol Oncol, 2002, 85, 170-174.
C. H. Petter, N. Heigl, M. Rainer, R. Bakry, J. Pallua, G. K. Bonn
and C. W. Huck, Curr Med Chem, 2009, 16, 318-326.
A. Podshyvalov, R. K. Sahu, S. Mark, K. Kantarovich, H.
Guterman, J. Goldstein, R. Jagannathan, S. Argov and S.
Mordechai, Appl Opt, 2005, 44, 3725-3734.
B. Rigas, K. LaGuardia, L. Qiao, P. S. Bhandare, T. Caputo and M.
A. Cohenford, J Lab Clin Med, 2000, 135, 26-31.
R. Sindhuphak, S. Issaravanich, V. Udomprasertgul, P. Srisookho,
S. Warakamin, S. Sindhuphak, R. Boonbundarlchai and N.
Dusitsin, Gynecol Oncol, 2003, 90, 10-14.
W. Steller, J. Einenkel, L. C. Horn, U. D. Braumann, H. Binder, R.
Salzer and C. Krafft, Anal Bioanal Chem, 2006, 384, 145-154.
M. J. Walsh, M. N. Singh, H. M. Pollock, L. J. Cooper, M. J.
German, H. F. Stringfellow, N. J. Fullwood, E. Paraskevaidis, P. L.
Martin-Hirsch and F. L. Martin, Biochem Biophys Res Commun,
2007, 352, 213-219.
B. R. Wood, L. Chiriboga, H. Yee, M. A. Quinn, D. McNaughton
and M. Diem, Gynecol Oncol, 2004, 93, 59-68.

Journal Name, [year], [vol], 00–00 | 9

41.
42.
5

43.

44.
10

45.
46.
15

47.
48.
20

49.

50.
25

51.
52.
30

53.

54.
35

B. R. Wood, M. A. Quinn, B. Tait, M. Ashdown, T. Hislop, M.
Romeo and D. McNaughton, Biospectroscopy, 1998, 4, 75-91.
H. M. Yazdi, M. A. Bertrand and P. T. Wong, Acta Cytol, 1996,
40, 664-668.
J. M. Schubert, B. Bird, K. Papamarkakis, M. Miljkovic, K.
Bedrossian, N. Laver and M. Diem, Lab Invest, 2010, 90, 10681077.
K. M. Ostrowska, A. Malkin, A. Meade, J. O'Leary, C. Martin, C.
Spillane, H. J. Byrne and F. M. Lyng, Analyst, 2010, 135, 30873093.
A. D. Meade, C. Clarke, F. Draux, G. D. Sockalingum, M. Manfait,
F. M. Lyng and H. J. Byrne, Anal Bioanal Chem, 2010.
P. Bassan, A. Kohler, H. Martens, J. Lee, H. J. Byrne, P. Dumas, E.
Gazi, M. Brown, N. Clarke and P. Gardner, Analyst, 2010, 135,
268-277.
T. Sano, T. Oyama, K. Kashiwabara, T. Fukuda and T. Nakajima,
Pathol Int, 1998, 48, 580-585.
R. Klaes, T. Friedrich, D. Spitkovsky, R. Ridder, W. Rudy, U.
Petry, G. Dallenbach-Hellweg, D. Schmidt and M. von Knebel
Doeberitz, Int J Cancer, 2001, 92, 276-284.
N. Murphy, M. Ring, A. Killalea, V. Uhlmann, M. O'Donovan, F.
Mulcahy, M. Turner, E. McGuinness, M. Griffin, C. Martin, O.
Sheils and J. O'Leary, J Clin Pathol, 2003, 56, 56-63.
K. Milde-Langosch, S. Riethdorf, A. Kraus-Poppinghaus, L.
Riethdorf and T. Loning, Virchows Arch, 2001, 439, 55-61.
S. N. Agoff, P. Lin, J. Morihara, C. Mao, N. B. Kiviat and L. A.
Koutsky, Mod Pathol, 2003, 16, 665-673.
N. Murphy, C. C. Heffron, B. King, U. G. Ganuguapati, M. Ring,
E. McGuinness, O. Sheils and J. J. O'Leary, Virchows Arch, 2004,
445, 610-615.
N. Murphy, M. Ring, C. C. Heffron, B. King, A. G. Killalea, C.
Hughes, C. M. Martin, E. McGuinness, O. Sheils and J. J. O'Leary,
J Clin Pathol, 2005, 58, 525-534.
S. S. Wang, M. Trunk, M. Schiffman, R. Herrero, M. E. Sherman,
R. D. Burk, A. Hildesheim, M. C. Bratti, T. Wright, A. C.
Rodriguez, S. Chen, A. Reichert, C. von Knebel Doeberitz, R.
Ridder and M. von Knebel Doeberitz, Cancer Epidemiol
Biomarkers Prev, 2004, 13, 1355-1360.

10 | Journal Name, [year], [vol], 00–00

55.
40

56.
57.
45

58.
59.
50

60.
61.
62.

55

63.
64.
65.

60

66.

67.
65

68.
70

69.

Z. Movasaghi, S. Rehman and I. U. Rehman, Appl. Spectrosc. Rev.,
2007, 42, 493-541.
J. W. Black and P. Leff, Proc R Soc Lond B Biol Sci, 1983, 220,
141-162.
G. Lizard, M. C. Chignol, Y. Chardonnet, C. Souchier, M. Bordes,
D. Schmitt and J. P. Revillard, J Immunol Methods, 1993, 157, 3138.
K. Adler, T. Erickson and M. Bobrow, Histochem Cell Biol, 1997,
108, 321-324.
G. Mehés, N. Speich, M. Bollmann and R. Bollmann, Pathol Oncol
Res, 2004, 10, 142-148.
E. M. Burd, Clin Microbiol Rev, 2003, 16, 1-17.
F. A. Suprynowicz, G. L. Disbrow, E. Krawczyk, V. Simic, K.
Lantzky and R. Schlegel, Oncogene, 2008, 27, 1071-1078.
K. M. Ostrowska, A. Malkin, A. D. Meade, J. J. O'Leary, C.
Martin, C. O. Spillane, H. J. Byrne and F. M. Lyng, Analyst, 2010.
P. T. Wong, R. K. Wong, T. A. Caputo, T. A. Godwin and B.
Rigas, Proc Natl Acad Sci U S A, 1991, 88, 10988-10992.
J. Doorbar, Clin Sci (Lond), 2006, 110, 525-541.
N. Murphy, C. C. Heffron, B. King, U. G. Ganuguapati, M. Ring,
E. McGuinness, O. Sheils and J. J. O'Leary, Virchows Arch., 2004,
445, 610-615. Epub 2004 Sep 2018.
M. Benevolo, M. Mottolese, F. Marandino, G. Vocaturo, R.
Sindico, G. Piperno, L. Mariani, I. Sperduti, P. Canalini, R. P.
Donnorso and A. Vocaturo, Mod Pathol, 2006, 19, 384-391.
B. Passamonti, D. Gustinucci, P. Recchia, S. Bulletti, A. Carlani,
E. Cesarini, M. R. D'Amico, V. D'Angelo, E. Di Dato, N.
Martinelli, M. Malaspina and N. Spita, Pathologica, 2010, 102, 611.
G. Negri, G. Bellisano, G. F. Zannoni, F. Rivasi, A. Kasal, F.
Vittadello, S. Antoniazzi, G. Faa, R. Ambu and E. Egarter-Vigl,
Am J Surg Pathol, 2008, 32, 1715-1720.
G. R. Focchi, I. D. Silva, N. C. Nogueira-de-Souza, C. Dobo, C. T.
Oshima and J. N. Stavale, J Low Genit Tract Dis, 2007, 11, 98104.

75

This journal is © The Royal Society of Chemistry [year]

